BRPI0921507A2 - composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo - Google Patents

composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo

Info

Publication number
BRPI0921507A2
BRPI0921507A2 BRPI0921507A BRPI0921507A BRPI0921507A2 BR PI0921507 A2 BRPI0921507 A2 BR PI0921507A2 BR PI0921507 A BRPI0921507 A BR PI0921507A BR PI0921507 A BRPI0921507 A BR PI0921507A BR PI0921507 A2 BRPI0921507 A2 BR PI0921507A2
Authority
BR
Brazil
Prior art keywords
preparation
excipient
composition
pharmaceutical tablet
tablet
Prior art date
Application number
BRPI0921507A
Other languages
English (en)
Portuguese (pt)
Inventor
James Farina
Liliana Miinea
Nandu Deorkar
Sameer Randive
Original Assignee
Avantor Performance Mat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantor Performance Mat Inc filed Critical Avantor Performance Mat Inc
Publication of BRPI0921507A2 publication Critical patent/BRPI0921507A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BRPI0921507A 2008-11-19 2009-11-16 composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo BRPI0921507A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11602508P 2008-11-19 2008-11-19
PCT/US2009/064498 WO2010059534A2 (en) 2008-11-19 2009-11-16 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Publications (1)

Publication Number Publication Date
BRPI0921507A2 true BRPI0921507A2 (pt) 2016-01-19

Family

ID=42077071

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921507A BRPI0921507A2 (pt) 2008-11-19 2009-11-16 composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo

Country Status (13)

Country Link
US (1) US20110288146A1 (enExample)
EP (1) EP2376067A2 (enExample)
JP (1) JP2012509329A (enExample)
KR (1) KR20110089180A (enExample)
CN (1) CN102215825A (enExample)
AU (1) AU2009316812A1 (enExample)
BR (1) BRPI0921507A2 (enExample)
CA (1) CA2744142A1 (enExample)
IL (1) IL212955A0 (enExample)
MX (1) MX2011005168A (enExample)
SG (1) SG171752A1 (enExample)
TW (1) TW201023897A (enExample)
WO (1) WO2010059534A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101298788B1 (ko) * 2011-03-15 2013-08-22 보령제약 주식회사 안정성이 개선된 복합제제
EP2842986B1 (en) * 2012-04-27 2018-12-26 Japan Corn Starch Co., Ltd. Method for producing starch granules, and orally disintegrating tablet
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
US20150343075A1 (en) * 2014-06-02 2015-12-03 Aimmune Therapeutics Placebo formulations and uses thereof
CN104189915B (zh) * 2014-07-30 2016-08-10 上海新亚药业闵行有限公司 一种固体制剂预混剂及其制备方法
CN104258411A (zh) * 2014-09-19 2015-01-07 安徽山河药用辅料股份有限公司 一种硅化微晶纤维素复合辅料及其制备方法
CN106265077A (zh) * 2015-05-30 2017-01-04 天士力制药集团股份有限公司 一种中药浸膏雾化分散工艺及其制剂
JP6650750B2 (ja) * 2015-12-22 2020-02-19 アサヒグループ食品株式会社 錠剤の製造方法、錠剤原料用顆粒の製造方法、及び錠剤原料用顆粒
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
CA3123605A1 (en) 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
HRP20231531T1 (hr) 2019-11-20 2024-03-01 Swedish Match North Europe Ab Nikotinski proizvod u vrećici za oralnu upotrebu koji uključuje materijal za punjenje koji sadržava čestice nikotina
EP4018848B1 (en) 2020-12-22 2024-09-18 Swedish Match North Europe AB A pouched product for oral use comprising a liquid permeable cover material and a filling material
CN116036291B (zh) * 2022-08-31 2025-08-26 瑞普（天津）生物药业有限公司 一种具有增溶作用的组合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
CA2126441C (en) * 1991-12-30 1999-12-21 David F. Erkoboni Microcrystalline cellulose spheronization composition
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
DE59914598D1 (de) * 1999-07-19 2008-02-14 Fit Gmbh Coprozessiertes Polysaccharidprodukt mit unlöslicher Carboxymethylcellulose
CN1222318C (zh) * 2000-11-06 2005-10-12 旭化成株式会社 制剂用纤维素粒子
CA2437375A1 (en) * 2001-02-05 2002-08-15 R.P. Scherer Technologies, Inc. Methods and compositions for reducing the taste of pharmaceutically active agents
CA2644400C (en) * 2005-02-03 2014-04-08 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
WO2008020990A1 (en) * 2006-08-09 2008-02-21 Mallinckrodt Baker, Inc. New direct compressible excipient blend
DE602007011792D1 (de) * 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
WO2009048557A1 (en) * 2007-10-10 2009-04-16 Mallinckrodt Baker, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Also Published As

Publication number Publication date
SG171752A1 (en) 2011-07-28
CA2744142A1 (en) 2010-05-27
MX2011005168A (es) 2011-05-30
TW201023897A (en) 2010-07-01
JP2012509329A (ja) 2012-04-19
CN102215825A (zh) 2011-10-12
KR20110089180A (ko) 2011-08-04
US20110288146A1 (en) 2011-11-24
WO2010059534A3 (en) 2011-01-20
IL212955A0 (en) 2011-07-31
AU2009316812A1 (en) 2011-07-07
EP2376067A2 (en) 2011-10-19
WO2010059534A2 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
DK2273975T3 (da) Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser
BR112012003842A2 (pt) composição farmacêutica, método de formulação e uso da mesma
HUE053357T2 (hu) Gyógyszerészeti készítmény és annak beadásai
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
HRP20161312T1 (hr) Postupak za pripravu farmaceutske formulacije kontrastnih sredstava
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0919796A2 (pt) formulação farmacêutica líquida livre de açúcar, e, excipiente líquido livre de açucar farmaceuticamente aceitável
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BR112013015796A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica.
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
EP2429987A4 (en) AMID COMPOUND, PHARMACEUTICAL METHOD AND PHARMACEUTICAL COMPOSITION THEREFOR
BRPI0915680A2 (pt) miméticos de glicocorticoide, métodos de prepará-los, composições farmacêuticas, e usos dos mesmos
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
DK2432456T3 (da) Faste farmaceutiske sammensætninger og fremgangsmåder til fremstilling deraf
BR112012023355A2 (pt) composto, composição farmacêutica e método de ruptura da interação nek2/hec1
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
BRPI0921654A2 (pt) formulação farmacêutica
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]